A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Recruiting now · Phase 2
Conditions studied: Hypercholesterolemia
In brief
This study is researching an experimental drug called alirocumab, referred to as "study drug". In the United States, alirocumab is approved for the treatment of hypercholesterolemia (high blood cholesterol levels). The aim of the study is to see how safe and effective alirocumab is when given weekly to adult participants who have hypercholesterolemia. The study is looking at several other research questions, including: * What side effects may happen from taking the study drug once a week * How much study drug is in the blood at different times
Key facts
- Study ID
- NCT07477704
- Run by
- Regeneron Pharmaceuticals
- People needed
- 420
- Starts
- 2026-06-17
- Expected to finish
- 2027-02-23
- Last updated by the study team
- 2026-07-22
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Pinnacle Research Group — Anniston, Alabama, United States (enrolling)
- Cullman Clinical Trials — Cullman, Alabama, United States (enrolling)
- Anaheim Clinical Trials — Anaheim, California, United States (enrolling)
- Cenexel CNS — Los Alamitos, California, United States (enrolling)
- Diablo Clinical Research - Flourish Research — Walnut Creek, California, United States (enrolling)
- Tampa Bay Medical Research — Clearwater, Florida, United States (enrolling)
- Southwest General Healthcare Center — Fort Myers, Florida, United States (enrolling)
- Precision Clinical Research — Sunrise, Florida, United States (enrolling)
- K2 Medical Research The Villages — The Villages, Florida, United States (enrolling)
- Center for Advanced Research and Education — Gainesville, Georgia, United States (enrolling)
- Balanced Life Health Care Solutions — Lawrenceville, Georgia, United States (enrolling)
- East-West Medical Research Institute — Honolulu, Hawaii, United States (enrolling)
- L-MARC Research Center — Louisville, Kentucky, United States (enrolling)
- Tandem Clinical Research — Marrero, Louisiana, United States (enrolling)
- Mercury Street Medical Group, PLLC — Butte, Montana, United States (enrolling)
- Velocity Clinical Research - Omaha — Omaha, Nebraska, United States (enrolling)
- Palm Research Center, Mountainview Medical Center — Las Vegas, Nevada, United States (enrolling)
- Velocity Clinical Research - Durham — Durham, North Carolina, United States (enrolling)
- Accellacare of Wilmington — Wilmington, North Carolina, United States (enrolling)
- Ohio Clinical Trials — Columbus, Ohio, United States (enrolling)
- AMR Norman — Norman, Oklahoma, United States (enrolling)
- Lynn Health Science Institute — Oklahoma City, Oklahoma, United States (enrolling)
- Velocity Clinical Research, Medford — Medford, Oregon, United States (enrolling)
- Altoona Center for Clinical Research — Duncansville, Pennsylvania, United States (enrolling)
- Tribe Clinical Research — Greenville, South Carolina, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.